Intracerebroventricular Administration of Metformin Inhibits Ghrelin-Induced Hypothalamic AMP-Kinase Signalling and Food Intake

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neuroendocrinology

• Publication date

  2012-02-14

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1159/000333963PMID 22343549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AMP-activated protein kinase (AMPK) activity is not required for neuronal development but regulates axogenesis during metabolic stress

  2011cited by this paper
• Clinical Pharmacokinetics of Metformin

  2011cited by this paper
• The anorexigenic effects of metformin involve increases in hypothalamic leptin receptor expression.

  2011cited by this paper
• The Central Sirtuin 1/p53 Pathway Is Essential for the Orexigenic Action of Ghrelin

  2011cited by this paper
• Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender

  2010cited by this paper
• Metabolic Regulation of Neuronal Plasticity by the Energy Sensor AMPK

  2010cited by this paper
• Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice.

  2010cited by this paper
• Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide

  2010cited by this paper
• Copyright © 2010 by Institute of Pharmacology Polish Academy of Sciences

  2010cited by this paper
• The importance of regulation of blood glucose levels through activation of peripheral 5'-AMP-activated protein kinase on ischemic neuronal damage.

  2010cited by this paper
• UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals

  2009cited by this paper
• Complex regulation of mammalian target of rapamycin complex 1 in the basomedial hypothalamus by leptin and nutritional status.

  2009cited by this paper
• LKB1 and AMP‐activated protein kinase control of mTOR signalling and growth

  2009cited by this paper
• Metformin increases plasma ghrelin in Type 2 diabetes.

  2009cited by this paper
• Metformin and body weight

  2008cited by this paper
• Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis.

  2008cited by this paper
• The Role of Hypothalamic Mammalian Target of Rapamycin Complex 1 Signaling in Diet-Induced Obesity

  2008cited by this paper
• AMPK: a key regulator of energy balance in the single cell and the whole organism

  2008cited by this paper
• Hypothalamic CaMKK2 contributes to the regulation of energy balance.

  2008cited by this paper
• UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals

  2008cited by this paper
• Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin.

  2008cited by this paper
• Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview.

  2008cited by this paper
• Metformin inhibits adenosine 5'-monophosphate-activated kinase activation and prevents increases in neuropeptide Y expression in cultured hypothalamic neurons.

  2007cited by this paper
• Amino acids inhibit Agrp gene expression via an mTOR-dependent mechanism.

  2007cited by this paper
• Hypothalamic mTOR Signaling Regulates Food Intake

  2006cited by this paper
• Metformin restores leptin sensitivity in high-fat-fed obese rats with leptin resistance.

  2006cited by this paper
• Cannabinoids and Ghrelin Have Both Central and Peripheral Metabolic and Cardiac Effects via AMP-activated Protein Kinase*

  2005cited by this paper
• Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein.

  2004cited by this paper
• Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats.

  2004cited by this paper
• Effects of high-fat feeding and fasting on ghrelin expression in the mouse stomach.

  2004cited by this paper
• Ghrelin increases food intake in obese as well as lean subjects

  2004cited by this paper
• AMP-activated Protein Kinase Plays a Role in the Control of Food Intake*

  2004cited by this paper
• Rapid Rewiring of Arcuate Nucleus Feeding Circuits by Leptin

  2004cited by this paper
• AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus

  2004cited by this paper
• Ghrelin-induced food intake is mediated via the orexin pathway.

  2003cited by this paper
• Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin.

  2003cited by this paper
• Tuberous sclerosis complex tumor suppressor–mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent

  2002cited by this paper
• A role for ghrelin in the central regulation of feeding

  2001cited by this paper
• Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.

  2001cited by this paper
• Role of AMP-activated protein kinase in mechanism of metformin action.

  2001cited by this paper
• Effect of metformin on nitric oxide synthase in genetically obese (ob/ob) mice.

  2001cited by this paper
• Metformin treatment enhances insulin-stimulated glucose transport in skeletal muscle of Sprague-Dawley rats.

  2000cited by this paper
• Ghrelin induces adiposity in rodents

  2000cited by this paper
• Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes.

  1998cited by this paper
• Effect of metformin on food intake in obese subjects

  1998cited by this paper
• Acute sympathoinhibitory actions of metformin in spontaneously hypertensive rats.

  1996cited by this paper
• Anorectic effect of metformin in obese Zucker rats: lack of evidence for the involvement of neuropeptide Y.

  1995cited by this paper
• Subchronic treatment with metformin produces anorectic effect and reduces hyperinsulinemia in genetically obese Zucker rats.

  1992cited by this paper
• Long-term recording of cerebrospinal fluid pressure in freely behaving rats.

  1988cited by this paper

• The adverse effect of a hypercaloric high‐fat diet feeding on hypothalamic cellular energy homeostasis is attenuated by a hypoglycemiant

  2025cites this paper
• Hypothalamic AMP-Activated Protein Kinase as a Whole-Body Energy Sensor and Regulator

  2024cites this paper
• Fecal Microbiota Transplantation, a tool to transfer healthy longevity.

  2024cites this paper
• Efficacy of metformin on the body mass index of patients under treatment with SSRI drugs referred to psychiatry clinics of Rasht

  2024cites this paper
• Recent advances in anti-inflammation via AMPK activation

  2024cites this paper
• Metabolic and Metabolomic Effects of Metformin in Murine Model of Pulmonary Adenoma Formation

  2023cites this paper
• The development and benefits of metformin in various diseases

  2023cites this paper
• Metformin acts as a dual glucose regulator in mouse brain

  2023cites this paper
• Research progress of treatment of functional dyspepsia with traditional Chinese medicine compound based on cell signal pathway

  2023cites this paper
• Repaglinide and metformin (diabetic treatments) enhance sexual efficiency

  2022cites this paper
• Weight-centric treatment of type 2 diabetes mellitus

  2022cites this paper
• Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight.

  2022cites this paper
• Non-Antibiotic and Non-Biologic Systemic Therapeutics

  2022cites this paper
• Efficacy and Side Effect Profile of Different Formulations of Metformin: A Systematic Review and Meta-Analysis

  2021cites this paper
• Metformin Causes Hepato-renal Dysfunctions in Obese Male Rats

  2021cites this paper
• p-Coumaric Acid Enhances Hypothalamic Leptin Signaling and Glucose Homeostasis in Mice via Differential Effects on AMPK Activation

  2021cites this paper
• Pharmacological strategies for insulin sensitivity: thiazolidinediones and metformin.

  2020cites this paper
• Efficacy and safety of the metformin-mazindol anorectic combination in rat

  2020cites this paper
• Metformin and Systemic Metabolism.

  2020cites this paper
• Acute Nicotine Treatment Alleviates LPS-Induced Impairment of Fear Memory Reconsolidation Through AMPK Activation and CRTC1 Upregulation in Hippocampus

  2020cites this paper
• Berberine attenuated olanzapine-induced metabolic alterations in mice: Targeting transient receptor potential vanilloid type 1 and 3 channels.

  2020cites this paper
• [The effect of metformin on lipid parameters and on cardiovascular risk in patients with type 2 diabetes without statin therapy].

  2019cites this paper
• Metformin: Mechanisms in Human Obesity and Weight Loss

  2019cites this paper
• Molecular Mechanisms of the Effects of Metformin on the Functional Activity of Brain Neurons

  2018cites this paper
• Effect of Metformin on Metabolic Parameters and Hypothalamic Signaling Systems in Rats with Obesity Induced by a High-Carbohydrate and High-Fat Diet

  2018cites this paper
• Metabolic parameters and functional state of hypothalamic signaling systems in AY/a mice with genetic predisposition to obesity and the effect of metformin

  2017cites this paper
• Metformin: A Hopeful Promise in Aging Research.

  2016cites this paper
• Betahistine and Metformin Reduce Weight and Affect Plasma Adiponectin and Nesfatin-1 Levels in Iraqi Obese Women

  2016cites this paper
• Age-dependent effects in fathead minnows from the anti-diabetic drug metformin.

  2016cites this paper
• Hypothalamic AMP-activated Protein Kinase as a Regulator of Food Intake and Energy Balance.

  2016cites this paper
• Molecular mechanisms of appetite and obesity: a role for brain AMPK.

  2016cites this paper
• Metformin aggravates immune-mediated liver injury in mice

  2015cites this paper
• Intracerebroventricular Metformin Decreases Body Weight But Has Pro-oxidant Effects and Decreases Survival

  2015cites this paper
• Synthesis and Evaluation of Optical and PET GLP-1 Peptide Analogues for GLP-1R Imaging

  2015cites this paper
• Metformin—mode of action and clinical implications for diabetes and cancer

  2014cites this paper
• Effects of metformin on weight loss: potential mechanisms

  2014cites this paper
• Branched-chain amino acids in metabolic signalling and insulin resistance

  2014cites this paper
• Hypothalamic mTOR: the rookie energy sensor.

  2014cites this paper
• Acute oral metformin enhances satiation and activates brainstem nesfatinergic neurons

  2014cites this paper
• The Growth Hormone Secretagogue Receptor: Its Intracellular Signaling and Regulation

  2014cites this paper
• Functionally biased signalling properties of 7TM receptors – opportunities for drug development for the ghrelin receptor

  2013cites this paper
• Metformin inhibits food intake and neuropeptide Y gene expression in the hypothalamus

  2013influential citation
• Integrative and Translational Physiology : Energy Homeostasis and Metabolic Disease Central administration of metformin into the third ventricle of C 57 BL / 6 mice decreases meal size and number and activates hypothalamic S 6 kinase

  2013cites this paper
• Running title : Central effect of metformin on energy homeostasis

  2013cites this paper
• Chronic Central Administration of Ghrelin Increases Bone Mass through a Mechanism Independent of Appetite Regulation

  2013cites this paper
• Loss of the Anorexic Response to Systemic 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside Administration Despite Reducing Hypothalamic AMP-Activated Protein Kinase Phosphorylation in Insulin-Deficient Rats

  2013cites this paper
• Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice.

  2013cites this paper
• Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications

  2012cites this paper